FDA Inspection
Pfizer Healthcare India Private LimitedPfizer Healthcare India Private Limited – FDA Inspection, Sep 10, 2026
Record Details
This FDA Inspection record concerns Pfizer Healthcare India Private Limited, with an inspection on September 10, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- September 10, 2026
- Product Type
- Human Drugs
View Company Profile
ID · 5a7580b0-2f3d-4759-a735-dae72d1335b7
Inspection Facts
- Inspection number
- 1335052
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.192Extent of discrepancy, failure investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pfizer Healthcare India Private Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| October 18, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 6, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 21, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 17, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 8, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pfizer Healthcare India Private Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.